Passage Bio

$15.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-2.14%) Today

$0.00 (0.00%) As of 9:14 PM UTC after-hours

Why Robinhood?

You can buy or sell Passage Bio and other stocks, options, and ETFs commission-free!

About PASG

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.

CEO

Bruce A. Goldsmith

Employees

Headquarters

Philadelphia, Pennsylvania

Founded

2017

Market Cap

881.96M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

299.01K

High Today

$16.49

Low Today

$15.67

Open Price

$16.35

Volume

689.49K

52 Week High

$38.23

52 Week Low

$12.10

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

PASG Earnings

-$1.00

-$0.67

-$0.33

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 10, Pre-Market